tirzepatide diabetic retinopathy risk Effect of on the of in type 2 diabetes Diabetes Distilled: Tirzepatide treatment associated

Sean Wharton, a leading obesity physician and internal medicine specialist in Toronto, says the GLP-1 drugs offer the scalable pharmacological intervention that has been missing for obese patients and an alternative to bariatric surgery that has its own risks

Yes Zepbound is tirzepatide

"While these changes are most pronounced on the face, they can also be seen in other parts of the body, including neck and buttocks, with sagging and wrinkling." GLP-1 medications may also contribute to hormonal and metabolic changes that can affect rapidly growing tissues like hair and nails

Wegovy is a GLP-1 receptor agonist, which means it works by activating receptors in the body that control appetite and blood sugar levels

Ask your doctor when you should stop and restart your GLP-1

5-10% body weight)